Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hsingwen Chung
Observed name:
Hsing-wen Chung
Institution:
Janssen Research & Development (United States)
Observed institutions:
McKesson (United States),
Johnson & Johnson (United States),
Janssen (United States),
The US Oncology Network,
Janssen Research & Development (United States)
ORCID:
0009-0009-3437-6624
Observed ORCID:
0009-0009-3437-6624
OpenAlex ID:
A5030390401
All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States
2010
·
Carl V. Asche
, Mendel E. Singer
, et al.
·
Journal of Managed Care Pharmacy
·
111
PDF
Safety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysis
2016
·
Nick Freemantle
, Engels Chou
, et al.
·
BMJ Open
·
63
PDF
Trends in the prevalence and incidence of ulcerative colitis in Japan and the US
2023
·
Michiyo Yamazaki
, Hsingwen Chung
, et al.
·
International Journal of Colorectal Disease
·
56
PDF
Survival Outcomes of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer Patients Treated in US Community Oncology
2012
·
Thomas H. Cartwright
, Yeun Mi Yim
, et al.
·
Clinical Colorectal Cancer
·
39
Dosing Patterns, Toxicity, and Outcomes in Patients Treated With First-Line Sunitinib for Advanced Renal Cell Carcinoma in Community-Based Practices
2014
·
Ian D. Schnadig
, Thomas E. Hutson
, et al.
·
Clinical Genitourinary Cancer
·
21
ALT Flare Predicts Hepatocellular Carcinoma Among Antiviral Treated Patients With Chronic Hepatitis B: A Cross-Country Cohort Study
2021
·
Yanan Du
, Bingying Du
, et al.
·
Frontiers in Oncology
·
20
PDF
Trends in the prevalence and incidence of Crohn’s disease in Japan and the United States
2024
·
Ko Nakajo
, Michiyo Yamazaki
, et al.
·
International Journal of Colorectal Disease
·
19
PDF
Current and forecasted 10-year prevalence and incidence of inflammatory bowel disease in Hong Kong, Japan, and the United States
2025
·
Yin Zhang
, Hsingwen Chung
, et al.
·
World Journal of Gastroenterology
·
18
Persistence of advanced therapies in patients with inflammatory bowel disease: retrospective cohort study using a large healthcare claims database in Japan
2024
·
Katsuyoshi Matsuoka
, Ko Nakajo
, et al.
·
Intestinal Research
·
9
Dose titration of osmotic release oral system methylphenidate in children and adolescents with attention-deficit hyperactivity disorder: a retrospective cohort study
2023
·
Youran Xu
, Hsingwen Chung
, et al.
·
BMC Pediatrics
·
7
PDF
Two Decades of Real-World Study in Newly Diagnosed Multiple Myeloma: Evolving Treatment and Outcomes in China with Reference to the United States
2025
·
Jingyu Xu
, Meng Shu
, et al.
·
Cancers
·
6
PDF
Treatment response monitoring in chronic phase CML (CP-CML) patients receiving tyrosine kinase inhibitor (TKI) therapy in US Oncology network.
2013
·
Kathryn S. Kolibaba
, Hsing-wen Chung
, et al.
·
Journal of Clinical Oncology
·
3
A Retrospective Cohort Study of Clinical Features and Treatment Patterns With Ustekinumab in Patients With Crohn Disease Utilizing a Health Care Database in Japan
2023
·
Yanfang Liu
, Choo Hua Goh
, et al.
·
Annals of Pharmacotherapy
·
1
Types, frequency, and adherence of molecular tests in chronic myelogenous leukemia at chronic phase (CML-CP) in the U.S. community setting.
2013
·
Clara Chen
, Lei Chen
, et al.
·
Journal of Clinical Oncology
·
1
Sunitinib dosing, toxicity, and outcomes in first-line advanced renal cell carcinoma (aRCC): A U.S. Oncology Network (USON) retrospective study.
2012
·
Ian D. Schnadig
, Thomas E. Hutson
, et al.
·
Journal of Clinical Oncology
·
1
Tu1820 PERSISTENCE OF ADVANCED THERAPIES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RETROSPECTIVE COHORT STUDY USING LARGE HEALTHCARE CLAIMS DATABASE IN JAPAN
2024
·
Katsuyoshi Matsuoka
, Shiho Kawamura
, et al.
·
Gastroenterology
Show more works
View as search
Works count:
16
Citation count:
375
H-index:
9
I10-index:
8
Year
Topic
Type